NET PROFIT (x1000 EUR)
EMPLOYEES
Scanpharm A/S
Closing information (x1000 EUR)
| Closing information | 2021/12 | 2020/12 | 2019/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-1,450
|
-2,298
|
-533 |
| Total assets |
3,888
|
4,332
|
4,707 |
| Current assets |
1,963
|
2,253
|
2,423 |
| Current liabilities |
3,155
|
3,378
|
3,317 |
| Equity capital |
202
|
257
|
788 |
| - share capital |
403
|
403
|
402 |
| Employees (average) |
75
|
75
|
35 |
Financial ratios
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Solvency |
5.2%
|
5.9%
|
16.7% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
62.2%
|
66.7%
|
73.0% |
| Return on equity (ROE) |
-717.8%
|
-894.2%
|
-67.6% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
40
|
0 |
| Chg. No. of employees % |
0%
|
114%
|
0% |
Total value of public sale
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.